Neuropathology Mapping | Quantitate amyloid, synuclein, and tau deposits

Use Case: Quantitate amyloid, synuclein, and tau deposits

Detect neuropathologies across brain regions: Examine the extent of naturally occurring pathologies in human brains afflicted with neurodegenerative disease.
Follow neuropathology progression: Study the biology of protein aggregate formation and spread across neural circuits in different animal models of neurodegenerative disease.
Monitor therapeutic efficacy: Measure the effect of therapeutic interventions on protein aggregate load in discrete regions of the brain for the treatment of various neurodegenerative diseases.

CAA pathology and tau accumulation. (a) Tissue from donor AD 6 shows areas with leptomeningeal CAA pathology, (b) tissue from donor AD 5 shows a rare CAA-positive vessel, (c) frequent CAA-positive vessels were observed in donor AD 1, (d) closeup of the dashed box in b, (e) closeup of the dashed box in d.

Figure 3, extracted from Hoglund, Z., Ruiz-Uribe, N., del Sastre, E. et al. Brain vasculature accumulates tau and is spatially related to tau tangle pathology in Alzheimer’s disease. Acta Neuropathol 147, 101 (2024). https://doi.org/10.1007/s00401-024-02751-9. This article is licensed under a Creative Commons Attribution 4.0 International License.

For additional publications supporting this use case refer to:

Our experienced team of application scientists have protocols to get you to data quickly with validated applications and can propose customized solutions for you for unvalidated applications. Fill the form below to get in touch with someone from the applications team today.

Speak to an expert about your application